KYTX Kyverna Therapeutics Inc.: Accounting Value per Share
The current share price of Kyverna Therapeutics (KYTX), which currently stands at 2.70, as shown on this chart, illustrates the dynamics of the biotech project. Kyverna Therapeutics is attracting leading specialists to develop cutting-edge treatments for systemic pathologies. The business is protected by exclusive patents and influence within US government agencies under strict FDA oversight. A narrow specialization in cellular technologies is offset by segment leadership and venture capital funding.
kyvernatx.com - analytical breakdowns and key metrics (KYTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Total Debt to Capital Kyverna Therapeutics|KYTX - Long-Term Debt to Capital|Short-Term Debt to Equity Kyverna Therapeutics, Inc.|KYTX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Kyverna Therapeutics, Inc.|KYTX - Company Long-Term Liabilities|Company Short-Term Debts Kyverna Therapeutics
Fundamental company valuation:Kyverna - KYTX
An investor determines an asset's margin of safety through the difference between the market price and the net asset value per share, calculated as the remaining equity minus preferred shares divided by the number of common shares. For Kyverna Therapeutics (KYTX), which develops patent-protected CAR-T therapies, the trend in book value per share reflects the capitalization of intellectual capital and the liquidity of the biotech startup.
Competitors of Kyverna Therapeutics (KYTX)
Accounting Value per Share Argenx ARGX|BioNTech Pharma (BNTX) - Book Price of a Share|Accounting Value per Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|AnaptysBio Inc - Net Asset Value per Share|Astria Pharma - Net Assets per Single Share|enGene Corp (ENGN) - Book Value per Share|Accounting Value per Share RAPT|Net Asset Value per Share Aerovate Therapeutics|Accounting Value per Share Aclaris Therapeutics, Inc.|Net Assets per Single Share Tiziana Life Sciences Ltd.|Cabaletta Bio, Inc - Book Value per Share|Net Asset Value per Share VTYX (Ventyx Biosciences, Inc)|Net Assets per Single Share Theratechnologies Inc.|avalotx.com - Accounting Value of a Share|Eledon Pharmaceuticals, Inc. (ELDN) - Net Assets per Single Share|AGEN - Equity per Share|CLYM: Book Value per Share|Book Value per Share Zura Bio Ltd|ATYR - Accounting Value per Share|Accounting Value of a Share Adagene Corp (ADAG)|Accounting Value per Share ImageneBio Inc|Book Price of a Share shattucklabs.com (STTK)|Book Value per Share Equillium|Accounting Value of a Share Connect Biopharma Holdings CNTB|IMUX (Immunic Inc) - Book Value per Share|ATRA: Net Asset Value per Share|Net Assets per Single Share inflarx.de IFRX|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value of a Share|ACET (Adicet Bio Inc.) - Book Value per Share|Book Value per Share CELU|INMB - Net Assets per Single Share|Share Book Value barinthusbio.com (BRNS)|KZR: Book Value per Share|SABS - Net Asset Value per Share|Akari Therapeutics plc - Accounting Value per Share|Enlivex Therapeutics (ENLV) - Book Value per Share|QTTB - Accounting Value per Share|geovax.com (GOVX) - Book Price of a Share|EDSA: Book Value per Share|Net Assets per Share iBio Inc|Book Value per Share CARM (Carisma Therapeutics)|Accounting Value per Share XTLB (XTL Bio)|Net Assets per Single Share BOLT|HCW Biologics, Inc. - Net Assets per Share|Aptevo - Net Assets per Single Share|AIM ImmunoTech, Inc. (AIM) - Book Value per Share|Accounting Value per Share ADTX|Net Asset Value per Share GRI Bio Corporation|XORTX Therapeutics Inc. (XRTX) - Accounting Value per Share|Book Price of a Share reshapelifesciences.com (HIND)|Accounting Value per Share Revelation Biosciences, Inc. REVB|Equity per Share INDP (Indaptus Therapeutics Inc)|Scinai (SCNI) - Net Assets per Single Share|Share Book Value CalciMedica Inc CALI|Book Value per Share Affimed Therapeutics (AFMD)|ALLK - Accounting Value of a Share|HOOK: Book Value per Share|IGMS (IGM Biosciences) - Book Value per Share|ITOS - Net Assets per Single Share|Accounting Value of a Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share thirdharmonicbio.com (THRD)